HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Fine Needle Biopsy

A fine needle biopsy (FNB) is a medical procedure used to obtain tissue samples from a suspicious or abnormal mass or lump in the body. This minimally invasive technique involves the use of a thin, hollow needle to extract a small tissue specimen for further examination. Fine needle biopsies are commonly performed to diagnose and analyze various medical conditions, including tumors, cysts, and infections. During the procedure, the patient may be positioned lying down or seated, depending on the location of the targeted mass. The area is typically cleaned and numbed with a local anesthetic to minimize discomfort. The healthcare professional then inserts the fine needle into the targeted area, guided by imaging techniques such as ultrasound or computed tomography (CT) scan. Once the needle is in place, a small sample of tissue is aspirated into a syringe or obtained using a vacuum technique. The collected tissue is then sent to a laboratory for pathological analysis. Pathologists examine the specimen under a microscope to identify any abnormal cellular changes or characteristics. Fine needle biopsy offers several advantages, including its less invasive nature, minimal scarring, and shorter recovery times compared to traditional surgical biopsies. Additionally, it is a valuable diagnostic tool for investigating the nature of a mass or lesion without the need for more extensive procedures. Despite its benefits, fine needle biopsy may not always provide a definitive diagnosis, and further testing or additional biopsies may be required for a comprehensive evaluation. Nevertheless, this procedure remains a crucial and widely utilized method for obtaining diagnostic information in a variety of medical scenarios.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp